General Home The History of Synthetic Biology Designing Synthetic Biotics Pipeline Our People Leadership Board of Directors Founders and Advisors Investors + Media Company Overview News News Releases In the News Events & Presentations Events Presentations Publications Stock Information Stock Quote & Chart Analyst Coverage Corporate Governance Governance Highlights Management Team Board of Directors Committee Composition Board Diversity Matrix Financials Quarterly Results Investor Resources FAQs Contact IR Email Alerts RSS Feeds code General Synlogic Announces Reverse Stock Split Read more about Synlogic Announces Reverse Stock Split Synlogic to Participate in Chardan’s Genetic Medicines Conference Read more about Synlogic to Participate in Chardan’s Genetic Medicines Conference Synlogic Announces CEO Aoife Brennan Named to PharmaVoice 100 Read more about Synlogic Announces CEO Aoife Brennan Named to PharmaVoice 100 Synlogic Granted Fast Track Designation from FDA for labafenogene marselecobac (SYNB1934) for Treatment of Phenylketonuria Read more about Synlogic Granted Fast Track Designation from FDA for labafenogene marselecobac (SYNB1934) for Treatment of Phenylketonuria Synlogic Announces International Nonproprietary Name Selection for SYNB1934 Read more about Synlogic Announces International Nonproprietary Name Selection for SYNB1934 Synlogic Announces Participation in SVB Securities Healthcare Therapeutics Forum Read more about Synlogic Announces Participation in SVB Securities Healthcare Therapeutics Forum Synlogic Reminds Stockholders of 2023 Annual General Meeting Details Read more about Synlogic Reminds Stockholders of 2023 Annual General Meeting Details Synlogic Announces Initiation of Synpheny-3 Global, Pivotal Phase 3 Study Evaluating SYNB1934 for Treatment of Phenylketonuria Read more about Synlogic Announces Initiation of Synpheny-3 Global, Pivotal Phase 3 Study Evaluating SYNB1934 for Treatment of Phenylketonuria Synlogic Announces Data Presentations at the 2023 Synthetic Biology: Engineering, Evolution & Design (SEED) Conference Read more about Synlogic Announces Data Presentations at the 2023 Synthetic Biology: Engineering, Evolution & Design (SEED) Conference Synlogic to Present at the Jefferies Global Healthcare Conference Read more about Synlogic to Present at the Jefferies Global Healthcare Conference Pagination Previous page ‹‹ Page 2 Next page ›› Subscribe to General Investor Resources Contact IR Investor FAQs RSS Feeds Investor Email Alerts Email
Synlogic to Participate in Chardan’s Genetic Medicines Conference Read more about Synlogic to Participate in Chardan’s Genetic Medicines Conference
Synlogic Announces CEO Aoife Brennan Named to PharmaVoice 100 Read more about Synlogic Announces CEO Aoife Brennan Named to PharmaVoice 100
Synlogic Granted Fast Track Designation from FDA for labafenogene marselecobac (SYNB1934) for Treatment of Phenylketonuria Read more about Synlogic Granted Fast Track Designation from FDA for labafenogene marselecobac (SYNB1934) for Treatment of Phenylketonuria
Synlogic Announces International Nonproprietary Name Selection for SYNB1934 Read more about Synlogic Announces International Nonproprietary Name Selection for SYNB1934
Synlogic Announces Participation in SVB Securities Healthcare Therapeutics Forum Read more about Synlogic Announces Participation in SVB Securities Healthcare Therapeutics Forum
Synlogic Reminds Stockholders of 2023 Annual General Meeting Details Read more about Synlogic Reminds Stockholders of 2023 Annual General Meeting Details
Synlogic Announces Initiation of Synpheny-3 Global, Pivotal Phase 3 Study Evaluating SYNB1934 for Treatment of Phenylketonuria Read more about Synlogic Announces Initiation of Synpheny-3 Global, Pivotal Phase 3 Study Evaluating SYNB1934 for Treatment of Phenylketonuria
Synlogic Announces Data Presentations at the 2023 Synthetic Biology: Engineering, Evolution & Design (SEED) Conference Read more about Synlogic Announces Data Presentations at the 2023 Synthetic Biology: Engineering, Evolution & Design (SEED) Conference
Synlogic to Present at the Jefferies Global Healthcare Conference Read more about Synlogic to Present at the Jefferies Global Healthcare Conference